Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The common shareholders would get absolutely nothing from a lawsuit. I look at the hiring as a positive that there is still hope that a deal maybe in reach. When they really start slashing headcount. Well then we could be at the end of our rope
The phase 3 study with BMY that they continue to talk about is a joke/fantasy right now until someone can provide information on who is paying for this phase 3 but because you know we sure as hell don’t have the money
The one thing Tony did mention was that a deal for AXAL would have to include more than just The EU. Which I have said all a long why would BP or someone else only want part of Europe after Dan went and made a bunch of stupid smaller deals for some of the biggest Cervical cancer areas. Whoever wants the deal I’m sure they want rights to the U.S. in the future
So let me get this right? Tony did all the work and turned it over to Ken and said once the hold is lifted. Just get them to sign and the credit, bonuses and anything else is all yours. Sounds about right! How about this!!! There has been no CEO in charge since Dan left. Tony was hired knowing they were giving Dan the boot. The BOD has been making all the decisions while Tony just sat around and did what was asked of him. It took the company a lot longer to find a replacement then they thought it would and now we are suck with what seems to be a big question mark of a CEO and all hoping and praying these next few months go well or it’s OVER
I hope so!!
The hold being lifted isn’t going to do squat. Nobody even seems to care about that combo trial. At one point it seemed like they were going to drop this partnership anyway. WE NEED THE NEO TRIAL TO DOSE ITS FIRST PATIENT AND WE NEED SOME REALLY OUTSTANDING DATA FROM COMBO IN PSA
I thought they said they were putting an ICFO in place for now. While they search for a new CFO. That could be another 6 months
I know NEO trial is listed as recruiting but until I see first patient dosed. It hasn’t started in my book. Fingers crossed still 8 weeks to hit this milestone
Wow Ken Berlin’s picture on the Advaxis website. Is the same picture I found used in PR in 2009. Almost ten years ago. Didn’t even have the decency to use an updated picture. I wonder why? Almost like going on a dating site and finding out the person you’re talking to has been using a ten year old photo. How would that make you feel. Looks like we got ourselves another real winner. Time is running out and NEO trial has still not started. Got a feeling PSA data isn’t going to be anything special. HOW DID WE GET HERE!!! REALLY HOW!! Just disgusting
Should have happen a long time ago. Might be just a little to late now
Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit
Omg how could TC!! My feelings are so hurt, lol!
Our graves are being dug as we speak and there isn’t much time left to turn this around.
It just goes to show you that not to many wanted the job and this CEO was probably one of our only choices.
If Amgen terminates our deal. That will definitely be the nail in the coffin. I hope to God these two new hires turn out to be great but not really excited about them at all.
Why is this his third CMO job in 2 1/2 years?
Wow he was at Sellas for less then a year. Guess things went real well and his last company since Dec 2016. So basically another year. Now onto his third company in about 2 1/2 years. Wow!! Just Wow!! People still try to find a way to put a positive on everything thing
You are right my apologies
One of the biggest milestones over the next two months is start of NEO. Which was already delayed for what we still don’t know but any more delays would most likely be devastating to this trial and this is just one of a handful of milestones for mid-year. JMO, good luck to us all. Hope some questions start to get answered starting next week
Sounds like Noelle is having some fun with some of you, lmao!!!!! Just over 2 months left to see if we fly or die
Hope your right!! That would be nice to get someone with that kind of experience
Thank you!!! Well for me it’s become clear. The company has decided not to answer or reply to questions from retail investors. When there is news they will release a PR but we are not in any quiet period. We can only hope all milestones set for mid year are hit because it’s fast approaching
Does anyone know?? If there are any rules or regulations that the company has to respond to questions from investors. It just seems like they went quiet right after the ASH meeting. So maybe once everything was approved and they got the additional shares they needed. They just decided they had enough of the endless amount of questions daily from investors. So they just put us on ignore or is this not possible
2019!!!! I can only hope you meant 2018. If this year passes without a large partnership/cash infusion. Well then I guess we might be headed for more dilution. Shortly followed by a R/S. We need something big to happen in the next 2 1/2 months.
This pps sure is not acting like a company that’s in a black out to be sold. Something would have leaked by now and the pps would be on the rise. I hope we are not in for bad news
The BMY combo trial is a funny thing. They still talk about this phase 3 trial starting later this year but where will the funding come from for another phase 3. When right now we barely have enough money to keep the lights on for one more year
What the next 3 months could look like. Tony has hit his milestones so far so I’ll give him the benefit of the doubt.
1. New CEO & CMO
2. Start of phase 1 NEO trial
3. Updated ADXS/PSA at ASCO(not to excited about this yet hope I’m wrong)
4. Update on ongoing phase 3 study
5. Not sure about this one but 120 day EMA response with questions
6. Four poster presentations at AACR( not sure if there will be anything exciting here but hopefully)
Might be missing something. Next 90 days are big tell of where we are headed
I already stated this, that she was still listed. The truth probably is that one or two of the upper management have moved on. So when Advaxis had to update the corporate presentation they decided just to remove all so no questions be asked or have thoughts arise that things aren’t on the up&up but that’s not the case because investors are a little worried if you can’t tell. Love how Noelle has basically gone MIA and right after the annual shareholders meeting. What a coincidence!! Also let me remind all of you that always think everything is just fine and dandy and everything is always someone else’s fault but never Advaxis’s. We still have a trial with a HOLD in place. Which the FDA could turn around tomorrow and put all trials on hold, wake up!
ASCO Presentation will be garbage. A lot of hype for nothing! If the data was that good Merck would have already stepped up and made a deal. I love how it’s a combo trial but Merck isn’t even listed in the PR headline.
Who says they were canned? My bigger fear would be that they started leaving on their own. Not to say that is the case but something definitely seems to be going on there.
Someone throw us a life jacket. Looks like we are in trouble. Still no word from the trial that was put on hold either. Why is it that every other Bio that has a hold put on one of its trials. Has it resolved in days.
No one has confirmed or has confirmation that anybody has left the company. It is all just speculation right now but the selling yet again this morning doesn’t give me a good feeling
They would most likely clean house after a SALE not before
I did find Ranya Dajani’s contact info still listed under the partnership page but still would like clarification on all leadership positions. If everyone stays in place I still believe and hope the company has a fighting chance but if they start walking. That is a clear sign that things aren’t not good or headed in the wrong direction
Wow hadn’t even noticed that. Also checked the most recent CP and they usually have everyone listed but not anymore. This is a very big problem to me. Hopefully we can get some clarification tomorrow that all leadership is still in place
Can’t even climb back over $2 what a pos. 3 months left to make something big happen
Do we get a PR this AM or after the conference on the abstracts they are presenting.
But you didn’t go, so much for that. Why don’t you go ask your friends at that big firm for advice or the guy you met walking your dog that one time, lol. Most of the posters on this board like yourself. Just aren’t with it and most likely heavily medicated
Who cares waste of everybody’s time anyway. Hopefully they have everything cleaned up in time for the conference on the 23rd
Those who bought the shares in the latest offering can’t vote. Unless they move the date for the shareholders meeting. Which doesn’t look like it’s happening. So they probably have the votes they need. I voted yesterday and decided to vote NO on everything. I have personally had enough of the way things are going but I guess it won’t matter because others here love the way the BOD and management has treated us over the years. I guess those two BIG buyers Noelle spoke of didn’t buy more then 5% but the other thing about the offering is Sara B. clearly states in the last webcast that the offering was over subscribed. So doesn’t that mean the additional shares were purchased as well or do I have that incorrect.